Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4508 per EA under NDC 00378193093. Its NADAC has been published 264 times since May 12, 2021.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
Emtricitabine and Tenofovir Disoproxil FumarateStrength
200; 300 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378193093
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206436On Market Since
3/30/2021
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 264 times since May 12, 2021, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4508 per EA |
|---|---|
| All-time high | $45.8098 (May 12, 2021) |
| All-time low | $0.4258 (May 22, 2024) |
| 52-week high | $0.5904 |
| 52-week low | $0.4508 |
| Median price | $0.5855 |
| Average price | $1.1228 |
| Largest weekly change | -97.1% (Jun 2, 2021) |
| Weeks tracked | 264 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.4508 per EA (NDC 00378193093), effective May 27, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 99.0%. It has been tracked across 264 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since May 12, 2021, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.4258 (May 22, 2024) to a high of $45.8098 (May 12, 2021), with a median of $0.5855 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 00378193093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification